drugset / Trial / NCT00765687

Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates

NCT00765687

Phase 4 Completed 432 enrolled Sun Yat-sen University Novartis · collab
NaSingle-groupOpen-labelPrevention

Summary

A multicenter Prospective Study to assess the screening methods, parameter of NTX and the efficacy and safety of zoledronic acid treatment in addition to anti-tumor therapy in patients of non-small cell cancer with bone metastasis in china.

Timeline

Start
2008-08
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zoledronic acid Other / unclassified
Comparator Calcium carbonate Other / unclassified 500 mg
Comparator Vitamin D Other / unclassified 400 iu
Comparator Vitamin D Other / unclassified 500 iu